The compounds are oral small molecules based on three distinct mechanistic platforms: calcitonin gene-related peptide (CGRP) receptor antagonists, glutamate modulators, and myeloperoxidase inhibitors.

In addition, Biohaven has several other programs in development, including a CGRP-receptor antagonist for episodic and chronic migraine, and glutamate modulators for multiple neurologic and ...

Arthur Burns is a 1 st year MS student in the Neuroscience program working on his master’s project in our lab. He is characterizing modulators of glutamate transporters in conditioned place preference ...

The Italian biopharma said it had decided to press ahead with the new study after assessing results from 100 patients with TRS in open-label studies who received the glutamate modulator drug as an ...